Results of Annual General Meeting
March 31st, 2022
BiVictriX Therapeutics plc (AIM: BVX), an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience, today announces that at its Annual General Meeting, held today at 12.00pm, all resolutions were duly passed.
Related Stories
Head office
Copyright: BiVictriX Therapeutics plc 2023.
All Rights Reserved. Design & Development By Online Web Studio